Skip to main content

Drug Control: Long-Standing Problems Hinder U.S. International Efforts

NSIAD-97-75 Published: Feb 27, 1997. Publicly Released: Feb 27, 1997.
Jump To:
Skip to Highlights

Highlights

Pursuant to a congressional request, GAO summarized the findings from its previous work on international drug control and interdiction efforts, focusing on: (1) the effectiveness of U.S. efforts to combat drug production and the movement of drugs into the United States; (2) obstacles to implementation of U.S. drug control efforts; and (3) suggestions to improve the operational effectiveness of the U.S. international drug control efforts.

Recommendations

Matter for Congressional Consideration

Matter Status Comments
To ensure continuity and commitment to achieving the goals and objectives of the drug control strategy, Congress should consider providing ONDCP the authority to require that key U.S. drug control agencies develop and submit multiyear funding plans tied to the drug control strategy.
Closed – Implemented
Action necessary to implement this recommendation was passed by the House on October 21, 1997, as part of the legislation to reauthorize the ONDCP (H.R. 2610). A Senate committee reported legislation with similar language. However, the legislation was never enacted because of major differences on other parts of the bill (i.e., drug control targets and the length of time required to meet these targets).

Recommendations for Executive Action

Agency Affected Recommendation Status
Office of National Drug Control Policy To aid decisionmakers in planning improved counternarcotics efforts and using U.S. resources to their best advantage, the Director, ONDCP, should complete the development of a long-term plan with meaningful performance measures and multiyear funding needs that are linked to the goals and objectives of the international drug control strategy.
Closed – Implemented
In February 1998, ONDCP submitted the President's National Drug Control Strategy for 1998. This document proposes a 10-year framework to reduce illegal drug use and availability 50 percent by 2007. The strategy contains 10-year goals and objectives and performance measures to evaluate the effectiveness of the strategy and redirect it, when necessary. The strategy is supported by a 5-year, agency-specific budget.
Office of National Drug Control Policy To aid decisionmakers in planning improved counternarcotics efforts and using U.S. resources to their best advantage, the Director, ONDCP should, at least annually, review the progress made and adjust the plan, as appropriate.
Closed – Implemented
ONDCP issued a 10-year strategy with multiyear budget plans and performance measures in February 1998. Under House-passed legislation (H.R. 2610) and according to testimony by the ONDCP Director, the strategy will be reviewed annually and adjusted where necessary. The first annual report on the progress was submitted to Congress in March 1999.
Office of National Drug Control Policy To aid decisionmakers in planning improved counternarcotics efforts and using U.S. resources to their best advantage, the Director, ONDCP, should enhance support for the increased use of intelligence and technology to improve U.S. and other nations' efforts to reduce supplies of and interdict illegal drugs.
Closed – Implemented
A White House Task Force on the Coordination of Counterdrug Intelligence Centers and Activities has been created to review counterdrug-intelligence missions, activities, functions, and resources to determine how federal, state and local drug control efforts can be better supported by intelligence. The Task Force has completed its work and submitted a draft report to the Director of ONDCP. With regard to funding levels, the proposed FY1999 budget for drug-related intelligence activities has increased from $154.2 million in FY1997 to an estimated $196.5 in FY1999, a 27-percent increase. Funding for counterdrug research is expected to increase from $655.2 million in FY1997 to $725.1 million in FY1999.
Office of National Drug Control Policy To aid decisionmakers in planning improved counternarcotics efforts and using U.S. resources to their best advantage, the Director, ONDCP, should lead in developing a centralized lessons-learned data system to aid agency planners and operators in developing more effective counterdrug efforts.
Closed – Implemented
ONDCP has tasked the Data, Evaluation, and Interagency Coordination Subcommittee of the Drug Control Research, Data and Evaluation Committee with collecting and disseminating lessons-learned information for all drug control issues, to include international and interdiction activities. In addition, the subcommittee is examining existing federal collection and dissemination procedures, identifying shortcomings, and will recommend steps to improve the collection and dissemination of information throughout the drug control community.

Full Report

Office of Public Affairs

Topics

Developing countriesDrug traffickingDrugsInternational cooperationInternational relationsLaw enforcementPolitical corruptionSmugglingStrategic planningDrug control